Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FSLB2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,971
Award facts
- Contract value 100% obligated
- $4,971.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,971.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Beyfortus 50 mg/0.5 mL syringes. The contract, which is not set-aside and was competitively awarded, specifies performance completion by October 30, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant federal contracting relationships with the Defense Logistics Agency and supports critical medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates extensive experience delivering a broad spectrum of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This particular order for Beyfortus, a respiratory syncytial virus immunization product, reflects the contractor's role in supporting preventive healthcare initiatives within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FSLB2?
SPE2DB26FSLB2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FSLB2 worth?
The government has obligated $4,971 on SPE2DB26FSLB2.
Is contract SPE2DB26FSLB2 an order under another contract?
Yes. SPE2DB26FSLB2 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB26FSLB2 competed?
The extent of competition for SPE2DB26FSLB2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award